Pharmaceutical

Pfizer urges parents to take the pledge against meningitis

Pfizer urges parents to take the pledge against meningitis

Pfizer has kicked off a disease-awareness campaign, "Take Action Against Meningitis," urging parents to discuss vaccinations with their healthcare providers with paralympic snowboarder Amy Purdy.

Court clears the way for Celebrex generics

Court clears the way for Celebrex generics

Ruling voids FDA's take on reissued patents, settling a year of challenges by generic applicants

Five things for pharma marketers to know: Thursday, December 17

Five things for pharma marketers to know: Thursday, December 17

UCB generic deal falls through; agency hiring could spike in 2015; teenage prescription drug abuse is on the decline.

Latest orphan-drug approval marks 15th this year

Latest orphan-drug approval marks 15th this year

Swiss drugmaker Novartis received an FDA nod for rare disease treatment Signifor LAR Tuesday, as orphan drug approvals reach new heights.

Brain cancer candidate touted for melanoma

Studies by Australian company Novogen are said to demonstrate, for the first time, that a drug highly effective against brain cancers has the same high potency against melanoma.

Pfizer brings humor to menopause marketing

Pfizer brings humor to menopause marketing

The new approach shows "The Talk" has a sequel.

Five things for pharma marketers to know: Tuesday, December 16

Five things for pharma marketers to know: Tuesday, December 16

Bayer consolidates OTC creative portfolio; Genentech R&D head steps down; Novartis receives approval for orphan drug.

Genentech drug combo targets advanced melanoma

The treatment reduces risk by half compared to widely used Zelboraf.

Bayer loses cancer drug patent fight in India

Court clears the way for a Nexavar generic from Natco

Sanofi, Regeneron field pre-launch cholesterol IQ poll

Sanofi, Regeneron field pre-launch cholesterol IQ poll

The drugmakers, who have an experimental cholesterol medication in the works, are asking consumers what they know about heart health.


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.